Literature DB >> 27186302

miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675.

Peiheng He1, Ziji Zhang1, Guangxin Huang1, Hua Wang1, Dongliang Xu1, Weiming Liao1, Yan Kang1.   

Abstract

Increasing evidence has reported the significant roles of lncRNA or miRNAs in the biology of various diseases. This study was aimed to elucidate the potential roles of miR-141 and lncRNA H19 and H19-derived miR-675 in regulating osteoblasts proliferation and apoptosis and to explore its potential mechanism. miR-141 mimic or miR-141 inhibitor or siRNA-H19 or miR-675 inhibitor was transfected into human hFOB1.19 cells. The effects or miR-141 expression on H19 or miR-675 expression, on osteoblasts proliferation and apoptosis were analyzed. Moreover, effects of H19 and miR-675 expression on cell proliferation were also analyzed. The results showed that miR-141 was down-regulated in both hFOB1.19 cells and osteosarcoma tissues. The overexpressed miR-141 suppressed H19 and miR-675 expression in hFOB1.19 cells. Besides, miR-141 suppression significantly increased cell viability but this effect was blocked by silencing H19 or miR-675 inhibitor, which is similar to the effects on VEGF and IGF2 expression. Furthermore, miR-141 overexpression induced osteoblasts apoptosis, but decreased the levels of caspase-3 and the Bcl-2/Bax ratio. Taken together, our study revealed that tumor-suppressor miR-141 overexpression suppressed osteoblasts proliferation but induced apoptosis through down-regulating H19 or miR-675 in osteosarcoma. This study may provide theoretical basis for illustrating the interaction between lncRNA and miRNAs in osteosarcoma and for the therapeutic target of miR-141 in osteosarcoma treatment.

Entities:  

Keywords:  Osteoblasts; cell proliferation; lncRNA H19; lncRNA H19-derived miR-675; miR-141

Year:  2016        PMID: 27186302      PMCID: PMC4859907     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  31 in total

Review 1.  Targeting miRNAs in osteoblast differentiation and bone formation.

Authors:  Rong Hu; Hui Li; Wei Liu; Li Yang; Yan-Fei Tan; Xiang-Hang Luo
Journal:  Expert Opin Ther Targets       Date:  2010-10       Impact factor: 6.902

Review 2.  Real-time PCR for mRNA quantitation.

Authors:  Marisa L Wong; Juan F Medrano
Journal:  Biotechniques       Date:  2005-07       Impact factor: 1.993

3.  Re: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.

Authors:  Anthony Atala
Journal:  J Urol       Date:  2013-08-30       Impact factor: 7.450

4.  The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.

Authors:  Ming Zhuang; Wen Gao; Jing Xu; Ping Wang; Yongqian Shu
Journal:  Biochem Biophys Res Commun       Date:  2014-01-02       Impact factor: 3.575

5.  Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.

Authors:  K Seki; H Yoshikawa; K Shiiki; Y Hamada; N Akamatsu; K Tasaka
Journal:  Cancer Chemother Pharmacol       Date:  2000       Impact factor: 3.333

Review 6.  Vascular endothelial growth factor (VEGF) signaling in tumor progression.

Authors:  Robert Roskoski
Journal:  Crit Rev Oncol Hematol       Date:  2007-02-26       Impact factor: 6.312

7.  Regulation of vascular endothelial growth factor signaling by miR-200b.

Authors:  Young-Chul Choi; Sena Yoon; Yongsu Jeong; Jaeseung Yoon; Kwanghee Baek
Journal:  Mol Cells       Date:  2011-05-02       Impact factor: 5.034

8.  miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Authors:  Kevin B Jones; Zaidoun Salah; Sara Del Mare; Marco Galasso; Eugenio Gaudio; Gerard J Nuovo; Francesca Lovat; Kimberly LeBlanc; Jeff Palatini; R Lor Randall; Stefano Volinia; Gary S Stein; Carlo M Croce; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

Review 9.  Translational biology of osteosarcoma.

Authors:  Maya Kansara; Michele W Teng; Mark J Smyth; David M Thomas
Journal:  Nat Rev Cancer       Date:  2014-10-16       Impact factor: 60.716

10.  MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5.

Authors:  Tomohiro Itoh; Yoshinori Nozawa; Yukihiro Akao
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

View more
  19 in total

1.  Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.

Authors:  Peisen Huang; Li Wang; Qing Li; Xiaqiu Tian; Jun Xu; Junyan Xu; Yuyan Xiong; Guihao Chen; Haiyan Qian; Chen Jin; Yuan Yu; Ke Cheng; Li Qian; Yuejin Yang
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

2.  Circulating microRNA signature of steroid-induced osteonecrosis of the femoral head.

Authors:  Zheng Li; Chao Jiang; Xingye Li; William K K Wu; Xi Chen; Shibai Zhu; Chanhua Ye; Matthew T V Chan; Wenwei Qian
Journal:  Cell Prolif       Date:  2017-12-04       Impact factor: 6.831

3.  LncRNA PCAT7 promotes non-small cell lung cancer progression by activating miR-486-5p/CDK4 axis-mediated cell cycle.

Authors:  Wenting Geng; Mengru Qiu; Dongbin Zhang; Peng Li; Gangyi Sun; Xi Zhou
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

4.  Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial-mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells.

Authors:  Jing Li; YingYing Huang; XiaoJun Deng; ManLing Luo; XueFei Wang; HaiYan Hu; CiDi Liu; Mei Zhong
Journal:  Onco Targets Ther       Date:  2018-01-18       Impact factor: 4.147

Review 5.  Interaction and cross-talk between non-coding RNAs.

Authors:  Soichiro Yamamura; Mitsuho Imai-Sumida; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Cell Mol Life Sci       Date:  2017-08-24       Impact factor: 9.261

Review 6.  Long non-coding RNAs in osteosarcoma.

Authors:  Ruiling Chen; Gangyang Wang; Ying Zheng; Yingqi Hua; Zhengdong Cai
Journal:  Oncotarget       Date:  2017-03-21

7.  Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.

Authors:  Jingying Hou; Lingyun Wang; Quanhua Wu; Guanghui Zheng; Huibao Long; Hao Wu; Changqing Zhou; Tianzhu Guo; Tingting Zhong; Lei Wang; Xuxiang Chen; Tong Wang
Journal:  Stem Cell Res Ther       Date:  2018-04-19       Impact factor: 6.832

8.  [Expression of LncRNA AK09398 and Relationship with Prognosis in Patients with Small Cell Lung Cancer].

Authors:  Bin Liu; Xiaoqin Liu; Ye Yang; Jun Ge; Jing Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-11-20

9.  LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141.

Authors:  Ke Liu; Yi Hou; Yunke Liu; Jia Zheng
Journal:  J Biomed Sci       Date:  2017-07-18       Impact factor: 8.410

10.  MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A.

Authors:  Wei Luo; Hongbo He; Wenfeng Xiao; Qing Liu; Zhenhan Deng; Yaojuan Lu; Qian Wang; Qiping Zheng; Yusheng Li
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.